Literature DB >> 19386682

Incidence and aetiology of eosinophilic pleural effusion.

R Krenke1, J Nasilowski, P Korczynski, K Gorska, T Przybylowski, R Chazan, R W Light.   

Abstract

Although eosinophilic pleural effusion (EPE) has been a subject of numerous studies, its clinical significance still remains unclear. The aim of our study was to evaluate: 1) the relative incidence and aetiology of EPE; 2) the predictors of malignancy in patients with EPE; and 3) the relationship between repeated thoracentesis and pleural fluid eosinophilia. A retrospective analysis of 2,205 pleural fluid samples from 1,868 patients treated between 1995 and 2007 was performed. We identified 135 patients with EPE (7.2% of all patients with pleural effusion) and 153 EPE samples. The most common condition associated with EPE was malignancy (34.8%) followed by infectious (19.2%), unknown (14.1%), post-traumatic (8.9%) and miscellaneous (23.0%) pleural effusions. The incidence of malignancy was significantly higher in patients with a lower (< or =40%) pleural fluid eosinophil percentage. 40 patients with EPE underwent a second thoracentesis. In 16, eosinophilia was present in both pleural fluid samples, 14 revealed pleural fluid eosinophilia only after the second thoracentesis and 10 had eosinophilia only in the first pleural fluid sample. Pleural fluid eosinophilia should not be regarded as a predictor of nonmalignant aetiology. Probability of malignancy is lower in effusions with a high eosinophil percentage. The incidence of EPE in patients undergoing second thoracentesis is not different to that found during the first thoracentesis.

Entities:  

Mesh:

Year:  2009        PMID: 19386682     DOI: 10.1183/09031936.00197708

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

1.  Significance of congestive heart failure as a cause of pleural effusion: Pilot data from a large multidisciplinary teaching hospital.

Authors:  Piotr Korczyński; Katarzyna Górska; Damian Konopka; Dżamila Al-Haj; Krzysztof J Filipiak; Rafał Krenke
Journal:  Cardiol J       Date:  2018-11-08       Impact factor: 2.737

2.  Carbimazole-induced eosinophilic pleural effusion.

Authors:  Chris Ferguson; Claire Bradley; Joe Kidney
Journal:  BMJ Case Rep       Date:  2018-05-07

3.  Eosinophilic pleural effusion: a rare manifestation of hypereosinophilic syndrome.

Authors:  Ndubuisi C Okafor; Ayodeji A Oso; Amanke C Oranu; Steven M Wolff; John J Murray
Journal:  Case Rep Med       Date:  2010-01-12

4.  Warfarin-induced eosinophilic pleural effusion.

Authors:  Yong-Min Jo; Tae-Ho Park; Il-Hwan Jeong; Hyun-Jeong Kim; Ji-Hye Ahn; Woo-Jae Kim; Young-Rak Cho; Hee-Kyung Baek; Moo-Hyun Kim; Young-Dae Kim
Journal:  Korean Circ J       Date:  2011-02-28       Impact factor: 3.243

5.  Pleural fluid analysis: standstill or a work in progress?

Authors:  T Hassan; M Al-Alawi; S H Chotirmall; N G McElvaney
Journal:  Pulm Med       Date:  2012-02-01

6.  Olanzapine-induced eosinophilic pleuritis.

Authors:  Matthew Evison; Jayne Holme; Mohamed Alaloul; Helen Doran; Paul Bishop; Richard Booton; Nauman Chaudhry
Journal:  Respir Med Case Rep       Date:  2014-12-16

7.  Mesalamine-induced eosinophilic pleural effusion.

Authors:  Abdullah Al-Abcha; Fazal Raziq; Shouq Kherallah; Ahmad Alratroot
Journal:  BMJ Case Rep       Date:  2020-04-16

8.  Cutaneous myiasis with eosinophilic pleural effusion: A case report.

Authors:  Tao Fan; Yu Zhang; Yan Lv; Jing Chang; Brent A Bauer; Juan Yang; Cheng-Wei Wang
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

9.  Eosinophilic pleural effusion and giardiasis: A causal or a casual relationship?

Authors:  Urvinderpal Singh; Nishi Garg; Vishal Chopra
Journal:  Lung India       Date:  2013-01

10.  Adult Onset Still's Disease: A Case Report with a Rare Clinical Manifestation and Pathophysiological Correlations.

Authors:  Katerina M Antoniou; George A Margaritopoulos; Ioannis Giannarakis; Christianna Choulaki; Nikos Fountoulakis; Nikos M Siafakas; Prodromos Sidiropoulos
Journal:  Case Rep Med       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.